We previously showed that vaccination with RNA-LPX encoding for CD4+T cell neoantigens augments cellular responses generated by LRT via in situ release of tumor antigens in a mouse tumor model of colorectal carcinoma, CT26 [25]. Here, CD4 is linked to neoplasm.